Related Experiment Video
Updated: Dec 25, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Cancer Genetics and Therapeutic Opportunities in Urologic Practice
Jacob J Adashek1, Alex Leonard2, Jason Roszik3
1Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33606, USA.
Genetic alterations in genitourinary cancers, including renal cell carcinoma and prostate cancer, are increasingly understood. These findings guide new targeted therapies and potential screening strategies for these malignancies.
Area of Science:
- Oncology
- Genetics
- Urology
Background:
- Genitourinary tract tumors exhibit diverse genetic alterations.
- Understanding these genetic changes is crucial for advancing treatment strategies.
Purpose of the Study:
- To summarize current literature on genetic alterations in genitourinary tract tumors.
- To highlight novel associations and their therapeutic implications.
Main Methods:
- Literature review of genetic alterations in genitourinary malignancies.
- Analysis of specific DNA alterations and their patterns.
Main Results:
- Chromosome 3p loss in clear cell renal cell carcinoma linked to chromothripsis and 5q gain.
- Metastatic evolution patterns in clear cell renal cell carcinoma identified.
- First targeted therapy approved for urothelial carcinoma.
- Germline mutations in DNA repair genes and HOXB13 associated with prostate cancer.
Conclusions:
- Genetic associations across genitourinary cancers can inform screening.
- Novel targeted treatment strategies can be guided by these genetic findings.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...

